Brian Piekos
Director of Finance/CFO chez ELICIO THERAPEUTICS, INC.
Fortune : - $ au 31/03/2024
Profil
Brian Piekos is currently the Chief Financial Officer at Elicio Therapeutics, Inc. He previously worked as the Senior Director-Corporate Finance, Tax & Treasury at Cubist Pharmaceuticals LLC from 2010 to 2015.
From 2015 to 2020, he served as the Treasurer, Chief Financial & Accounting Officer at AMAG Pharmaceuticals, Inc. Brian also held the position of Chief Financial Officer at scPharmaceuticals, Inc. He briefly worked as the Chief Financial & Accounting Officer at Gemini Therapeutics, Inc. in 2021.
Mr. Piekos completed his undergraduate degree at Ithaca College and obtained a graduate degree from UMass Chan Medical School.
He also holds an MBA from the University of Rochester Simon Business School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ELICIO THERAPEUTICS, INC
-.--% | 01/02/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Brian Piekos
| Sociétés | Poste | Début |
|---|---|---|
| ELICIO THERAPEUTICS, INC. | Director of Finance/CFO | 01/05/2023 |
Anciens postes connus de Brian Piekos
| Sociétés | Poste | Fin |
|---|---|---|
| GEMI THER | Director of Finance/CFO | 29/12/2022 |
| AMAG PHARMACEUTICALS, INC. | Director of Finance/CFO | 01/12/2020 |
| CUBIST PHARMACEUTICALS INC | Comptroller/Controller/Auditor | 01/02/2015 |
| SCPHARMACEUTICALS INC. | Director of Finance/CFO | - |
Formation de Brian Piekos
| Ithaca College | Undergraduate Degree |
| UMass Chan Medical School | Graduate Degree |
| University of Rochester Simon Business School | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| SCPHARMACEUTICALS INC. | Health Technology |
| ELICIO THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Cubist Pharmaceuticals LLC
 Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cubist Pharmaceuticals LLC operates as a biopharmaceutical company. It focuses on the research, development and commercialization of pharmaceutical products. The company was founded in 1992 and is headquartered in Lexington, MA. | Health Technology |
AMAG Pharmaceuticals, Inc.
 AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |
Gemini Therapeutics, Inc.
 Gemini Therapeutics, Inc. BiotechnologyHealth Technology Gemini Therapeutics, Inc. is a clinical-stage precision medicine company. It is developing novel therapeutic compounds to treat genetically defined, age-related macular degeneration. The company was founded by Johanna Seddon, Paul Barlow and Andrew Herbert on March 3, 2015 and is headquartered in Cambridge, MA. | Health Technology |
